Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

被引：0
|
作者：
Toshiyuki Iwahori
机构：
[1] Eli Lilly Japan K.K.,Medicines Development Unit Japan and Medical Affairs
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2441 / 2442
页数：1
相关论文
共 50 条
  • [41] Effectiveness and Safety of Weekly Administration of GLP-1 Receptor Agonist in Hemodialysis Patients with Type 2 Diabetes Mellitus
    Toyoda, Masao
    Kimura, Moritsugu
    Fukagawa, Masafumi
    [J]. DIABETES, 2016, 65 : A278 - A278
  • [42] Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
    Bolli, G. B.
    Owens, D. R.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 588 - 601
  • [43] SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes?
    Scheen, Andre J.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (11): : 818 - 820
  • [44] ALBIGLUTIDE Glucagon-Like Peptide GLP-1 Receptor Agonist Treatment of Type 2 Diabetes
    Rosenstock, Julio
    Stewart, Murray W.
    [J]. DRUGS OF THE FUTURE, 2010, 35 (09) : 701 - 712
  • [45] Efpeglenatide Glucagon-like peptide 1 (GLP-1) receptor agonist Treatment for type 2 diabetes
    Reid, J.
    Rana, K.
    Segel, S. A.
    Sheikh-Ali, M.
    Choksi, R. R.
    Goldfaden, R. F.
    [J]. DRUGS OF THE FUTURE, 2019, 44 (06) : 435 - 441
  • [46] A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus
    Thondam, S. K.
    Cuthbertson, D. J.
    Aditya, B. S.
    MacFarlane, I. A.
    Wilding, J. P.
    Daousi, C.
    [J]. CLINICAL ENDOCRINOLOGY, 2012, 77 (04) : 635 - 637
  • [47] Semaglutide (Ozempic) - Another Injectable GLP-1 Receptor Agonist for Type 2 Diabetes
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1539): : 19 - 21
  • [48] A Drug and Disease Model for Lixisenatide, a GLP-1 Receptor Agonist in Type 2 Diabetes
    Wilkins, Justin J.
    Dubar, Michel
    Sebastien, Bernard
    Laveille, Christian
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (03): : 267 - 278
  • [49] Effects of the GLP-1 Receptor Agonist on Fatty Liver in Patients With Type 2 Diabetes
    Ogino, Jun
    Yoneda, Chihiro
    Tajima, Kanako
    Ichimura, Yasuhiko
    Fukushima, Sayaka
    Haruki, Takenori
    Sakuma, Yukie
    Iwai, Rie
    Nishino, Takayoshi
    Suzuki, Yoshifumi
    Hashimoto, Naotake
    [J]. DIABETES, 2013, 62 : A256 - A257
  • [50] GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes
    Do, Duy
    Lee, Tiffany
    Peasah, Samuel K.
    Good, Chester B.
    Inneh, Angela
    Patel, Urvashi
    [J]. JAMA NETWORK OPEN, 2024, 7 (05)
12345